Page last updated: 2024-08-25

voriconazole and Hematologic Malignancies

voriconazole has been researched along with Hematologic Malignancies in 111 studies

Research

Studies (111)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (0.90)	18.2507
2000's	27 (24.32)	29.6817
2010's	69 (62.16)	24.3611
2020's	14 (12.61)	2.80

Authors

Authors	Studies
Garcia-Effron, G; Kontoyiannis, DP; Lewis, RE; Perlin, DS	1
Mehta, J; Pennick, G; Pi, J; Scheetz, MH; Trifilio, SM; Yarnold, PR	1
Carlesse, F; Colombo, AL; Kontoyiannis, DP; Nobrega de Almeida, J; Rossato, L	1
Bai, Y; Fan, XH; Hu, CJ; Ji, J; Li, M; Li, Q; Tan, L; Tan, R; Wen, ZP; Xia, BY; Yang, CL; Yang, JH; Yang, Y; Zhang, H; Zheng, XL; Zheng, ZC	1
Ergon, MC; Ertem, O; Gumustekin, M; Oren, H; Tufekci, O; Tuncok, Y	1
Chaphekar, N; Cheng, Y; Huang, H; Huang, W; Liu, M; Wu, X; Zheng, Y	1
Hashimoto, T; Hiramatsu, K; Itoh, H; Maeda, Y; Ogata, M; Takano, K; Tanaka, R; Tatsuta, R	1
Cesaro, S; Cornely, OA; Falces-Romero, I; Kindo, AJ; Klimko, N; Koehler, P; Kredics, L; Lass-Flörl, C; Meyer, E; Racil, Z; Sal, E; Salmanton-García, J; Seidel, D; Stemler, J; Wisplinghoff, H; Würstl, B	1
Doki, N; Fukushima, K; Funata, N; Hishima, T; Horiguchi, SI; Igarashi, A; Inamoto, K; Kaito, S; Kakihana, K; Kishida, Y; Kobayashi, T; Konishi, T; Kurosawa, S; Nagata, A; Najima, Y; Ohashi, K; Sakamaki, H; Sekiya, N; Shimizu, H; Shingai, N; Shirane, S; Toya, T; Uchida, T; Yamada, Y; Yoshifuji, K	1
Cai, R; Li, C; Liu, T; Lv, C; Qi, J; Wei, Y; Wu, D; Wu, Y; Zhou, S	1
Aguado, JM; Azanza, JR; Barberán, J; Cubillo Gracian, A; Dueñas Gutiérrez, C; Fortún, J; García-Vidal, C; González-Sierra, P; Gudiol, C; Kwon, M; Mensa, J; Olave Rubio, T; Pérez de Oteyza, J; Rovira Tarrats, M; Ruiz Camps, I; Salavert Lletí, M; Solano, C; Suárez-Lledó Grande, M; Vázquez, L; Yáñez, L	1
Aguilar-Zapata, D; Barragán-Reyes, A; Camacho, A; Cendejas, RF; Cornejo-Juárez, P; Guzmán, JMF; Hernández, MLG; Jácome, LEL; Juárez-Hernández, E; Nava-Ruiz, A; Ontañón-Zurita, D; Perales-Martínez, D; Reséndiz-Sánchez, J; Rincón-Zuno, J; Rivera-Martínez, NE	1
Aquino, V; Borges, R; Meneghello Fuentefria, A; Ramirez-Castrillon, M; Rosa, PDD; Zubaran Goldani, L	1
Azoulay, E; Calvet, L; Darmon, M; De Jong, A; Kerhuel, L; Lemiale, V; Mokart, D; Moreau, AS; Pardo, E; Stoclin, A; Valade, S	1
Busca, A; Calore, E; Candoni, A; Capelli, D; Castagnola, C; Cattaneo, C; Del Principe, MI; Facchin, G; Fanin, R; Klimko, N; Lazzarotto, D; Melillo, L; Nadali, G; Pagano, L; Perruccio, K; Verga, L; Zannier, ME	1
Moncada, D; Ramírez, I	1
Ding, XL; Liu, LN; Miao, LY; Tian, JX; Xue, L; Yan, HH; Zhang, JJ; Zhang, WJ; Zhang, WW	1
Li, H; Luo, J; Shi, L; Wang, L; Zeng, G; Zhang, Z; Zhu, M	1
Huang, FR; Shen, Y; Sun, LN; Wang, YQ; Zhang, HW; Zhang, XY; Zhou, C	1
Albert, ND; Heo, ST; Jiang, Y; Jiménez-Ortigosa, C; Kontoyiannis, DP; Lewis, RE; Meis, JF; Mikos, AG; Perlin, DS; Tarrand, J; Tatara, AM; Tverdek, F; Verweij, PE	1
Bachellier, P; Bru, V; Gourieux, B; Herbrecht, R; Launoy, A; Levêque, D; Lutun, P; Nivoix, Y; Poulat, C; Rohr, S; Woehl, ML	1
Gueta, I; Halkin, H; Kamari, Y; Livni, G; Loebstein, R; Markovits, N; Yarden-Bilavsky, H	1
Assaf, A; Chaftari, AM; Hachem, R; Jiang, Y; Numan, Y; Raad, II; Shah, P	1
Goldraich, L; Husain, S; Kabbani, D; Ross, H; Rotstein, C	1
Asano, S; Kato, K; Sakurada, H; Tachi, T; Teramachi, H; Yamamura, M; Yasuhara, K; Yoshida, M	1
Brizendine, KD; Cober, E; Johnson, L; Nambiar, P	1
Avila, AM; Barba, P; Cho, C; Devlin, S; Huang, YT; Maloy, MA; Montoro, J; Papanicolaou, GA; Perales, MA; Rosillo, C	1
Qiao, M; Qiu, HY; Sun, AN; Tang, L; Tang, XW; Wu, DP; Yang, XF; Zhang, L	1
Chauhan, V; Córdoba, R; de Jong, J; De Wilde, S; de Zwart, L; Hellemans, P; Jiao, J; Manikhas, G; Masterson, T; Myasnikov, A; Osmanov, D; Ouellet, D; Panizo, C; Patricia, D; Snoeys, J; Sukbuntherng, J	1
Anderson, A; Lin, T; McManus, D; Perreault, S; Ruggero, M; Topal, JE	1
Bentvelsen, RG; de Haan, AF; Kuiper, EJ; Lestrade, PP; Melchers, WJG; Rijnders, BJA; Schalekamp, S; Schauwvlieghe, AFAD; van der Beek, MT; van der Hoeven, HL; van der Hoven, B; van der Lee, HA; van der Velden, WJFM; van Paassen, J; Verweij, PE	1
Chaftari, AM; Dib, RW; Ghaly, F; Hachem, RY; Jiang, Y; Raad, I	1
Brüggemann, RJ; Hanff, LM; Henriet, S; Koch, BCP; Lempers, VJ; Mavinkurve-Groothuis, AM; Meuwese, E; van der Sluis, IM; Warris, A	1
Fang, JP; Huang, K; Li, Y; Liao, XY; Qiu, KY; Xu, HG; Zhou, DH	1
Bao, F; Hu, K; Liu, Y; Qiu, T; Wang, J; Zhang, C	1
Aram, JA; Chen, X; Jin, J; Liu, Y; Lou, YJ; Meng, H; Pan, S; Patterson, TF; Schwartz, IS; Wu, D; Yan, JL; Zhang, X	1
Cornelissen, JJ; De Kort, E; Lagrou, K; Lestrade, PPA; Maertens, J; Mercier, T; Resendiz-Sharpe, A; Rijnders, BJA; Schauwvlieghe, AFAD; van der Beek, MT; Verweij, PE; von dem Borne, PA	1
Aram, JA; Lee, DG; Lee, HJ; Lin, SS; Yan, JL	1
Bacci, F; Bertuzzi, C; Bonifazi, F; Cavo, M; Cricca, M; De Cicco, G; Lewis, RE; Paolini, S; Sassi, C; Stanzani, M; Sutto, E	1
Chu, HY; Fredricks, DN; Jain, R; Pottinger, P; Xie, H	1
Huitema, AD; Schellens, JH; Schouten-van Meeteren, AY; van Eijkelenburg, NK; van Hasselt, JG	1
Duettmann, W; Fruhwald, S; Hoenigl, M; Krause, R; Prueller, F; Raggam, RB; Seeber, K; Troppan, K; Valentin, T; Wagner, J; Wölfler, A; Zollner-Schwetz, I	1
Hino, M; Iino, M; Kanamaru, A; Koh, H; Masaoka, T; Ohta, K; Ohyashiki, K; Tamura, K; Tanimoto, M; Urabe, A; Urase, F; Usui, N; Yamaguchi, M; Yamanouchi, J; Yoshida, M	1
Gamaletsou, MN; Walsh, TJ	1
Chai, LY; Earnest, A; Herbrecht, R; Johnson, EM; Kullberg, BJ; Netea, MG; Schlamm, HT; Teerenstra, S; Troke, PF; Vonk, AG	1
Fung, HC; Peksa, GD; Schultz, K	1
Baker, KS; Cornell, C; Englund, JA; Johnson, D; Meshinchi, S; Parnell, S; Tarlock, K	1
Hachem, R; Helou, GE; Jiang, Y; Kontoyiannis, DP; Raad, II; Zakhem, AE	1
Ramos, MG; Rodríguez, ZC	1
Cassumbhoy, M; Chau, MM; Cooper, CM; Kong, DC; Marriott, DJ; Roberts, JA; Trubiano, JA; Urbancic, K; van Hal, SJ; Wilkes, J; Worth, LJ	1
Crowe, A; Slavin, MA; Thursky, KA; Trubiano, JA; Worth, LJ	1
Adel, NG; Barker, JN; Castro-Malaspina, H; Ceberio, I; Dai, K; Devlin, SM; Giralt, S; Goldberg, JD; Perales, MA	1
Bow, EJ; Cornely, OA; Heinz, WJ; Herbrecht, R; Jagannatha, S; Koh, LP; Kontoyiannis, DP; Lee, DG; Maertens, JA; Marr, KA; Nucci, M; Pappas, PG; Queiroz-Telles, F; Rottinghaus, ST; Schlamm, HT; Selleslag, D; Slavin, MA; Walsh, TJ; Wingard, JR	1
Cotton, D	1
Bartoli, M; Bulabois, CE; Cahn, JY; Fonrose, X; Gautier-Veyret, E; Quesada, JL; Stanke-Labesque, F; Thiebaut-Bertrand, A; Tonini, J	1
Barajas, MR; Bartoo, GT; Dierkhising, RA; El-Azhary, RA; Hashmi, SK; Hogan, WJ; Litzow, MR; Merten, JA; Patnaik, MM; Plevak, MF; Wilson, JW; Wojenski, DJ; Wolf, RC	1
Biswas, D; Dewan, E; Kakati, B; Kotwal, A; Oberoi, A; Verma, SK	1
Akagi, T; Ishida, Y; Ito, S; Kowata, S; Kubo, K; Murai, K; Oyake, T; Sawada, K	1
da Silva, CM; de Lima Neto, RG; de Morais, VL; Domingos, Ide F; Gonçalves, SS; Leite, EP; Macêdo, DP; Neves, RP; Parahym, AM; Rolim Neto, PJ	1
Cho, EY; Choi, EH; Kang, HJ; Kang, HM; Lee, H; Lee, HJ; Lee, JW; Park, KD; Shin, HY; Yu, KS	1
Bigliardi, S; Candoni, A; Cojutti, P; Fanin, R; Forghieri, F; Isola, M; Luppi, M; Pea, F; Zannier, ME	1
Kimura, S	1
Cho, SY; Choi, JH; Choi, JK; Choi, SM; Han, S; Kim, SH; Kwon, JC; Lee, DG; Lee, HJ; Lee, JW; Park, C; Park, SH; Yim, DS; Yoo, JH	1
Kato, S; Konuma, T; Kurokawa, Y; Takahashi, S; Tojo, A; Yasu, T	1
Cai, S; Guo, X; Ren, J; Yuan, W	1
Aitken, SL; Heo, ST; Kontoyiannis, DP; Tverdek, FP	1
Fujimoto, Y; Ikawa, K; Kanbayashi, Y; Nomura, K; Taniwaki, M	1
Imataki, O; Ishida, T; Kitanaka, A; Kubota, Y; Ohnishi, H; Tanaka, T	1
Caira, M; Fianchi, L; Pagano, L	1
Nawrot, U; Nowicka, J; Wlodarczyk, K	1
Hangaishi, A; Imai, Y; Kumano, K; Kurokawa, M; Nannya, Y; Takahashi, T; Ueda, K	1
Maschmeyer, G	1
Akin, M; Ay, Y; Balkan, C; Karapinar, B; Kavakli, K; Yilmaz, D	1
Berrak, SG; Cakir, E; Cakir, FB; Canpolat, C; Dagli, E; Karakoc, F; Uyan, ZS	1
Lagrou, K; Maertens, J; Meersseman, W; Saegeman, V; Spriet, I; Verbeken, E	1
Clancy, CJ; Cline, C; Jantz, MA; Kulkarni, V; Leather, H; Nguyen, MH; Wheat, LJ; Wingard, JR	1
Alanio, A; Botterel, F; Bretagne, S; Cordonnier, C; Costa, JM; Farrugia, C; Foulet, F; Hicheri, Y; Liance, M; Sitterlé, E	1
Chang, FY; Ho, SJ; Lin, JC; Shang, ST; Wang, NC; Yang, YS	1
Aiba, K; Dobashi, N; Kasama, K; Katsube, A; Machishima, T; Minami, J; Nishiwaki, K; Ogasawara, Y; Saito, T; Shimada, T; Sugiyama, K; Takahara, S; Takei, Y; Usui, N; Yahagi, Y; Yamaguchi, Y; Yano, S; Yokoyama, H	1
Delaunay, J; Fraissinet, F; Gastinne, T; Gibas, CF; Le Pape, P; Miegeville, M; Morio, F; Sigler, L	1
Choi, JH; Choi, SM; Han, S; Kim, SH; Kwon, EY; Kwon, JC; Lee, DG; Park, C; Park, SH; Yim, DS; Yoo, JH	1
Feng, AM; Wei, JY; Yu, WJ	1
Shen, YF; Sun, HL; Zhou, X	1
Bergeron, A; Ferry, C; Lacroix, C; Peffault de Latour, R; Petropoulou, A; Porcher, R; Ribaud, P; Robin, M; Rocha, V; Salmeron, G; Socié, G; Sulahian, A; Xhaard, A	1
Cook, G; Cordonnier, C; Hicheri, Y	1
Choi, SH; Chun, S; Kim, DY; Kim, SH; Kim, YS; Lee, JH; Lee, KH; Lee, SO; Lee, YJ; Woo, JH	1
Fasler, D; Gerber, B; Guggenberger, R; Manz, MG; Nair, G; Schanz, U; Stussi, G	1
Huang, XE; Shen, ZS; Su, AL; Xu, YL; Zhang, XQ; Zhang, XZ	1
Abu El-Naaj, I; Leiser, Y; Peled, M; Wolff, A	1
Estes, LL; Wilson, JW; Zeuli, JD	1
Dadwal, SS; Davies-Vorbrodt, S; Ito, JI; Kriengkauykiat, J; Tegtmeier, BR	1
Alaggio, R; Cecchetto, G; Cesaro, S; Cusinato, R; Pillon, M; Rigobello, L; Strugo, L; Zanesco, L	1
Baden, LR; DelVecchio, A; Doran, M; Fishman, JA; Katz, JT; Koziol, C; Rubin, RH	1
D'Antonio, D; Di Bonaventura, G; Picciani, C; Piccolomini, R; Spedicato, I	1
Mehta, J; Ortiz, R; Pennick, G; Pi, J; Stosor, V; Trifilio, S; Verma, A; Zembower, T	1
Böhme, A; Haas, A; Maschmeyer, G	1
Bonatti, H; Dierich, MP; Freund, M; Gastl, G; Griff, K; Kropshofer, G; Lass-Flörl, C; Mayr, A; Nachbaur, D; Petzer, A	1
Bethge, WA; Einsele, H; Hebart, H; Horger, M; Kanz, L; Kröber, SM; Schmalzing, M; Schumacher, U; Stuhler, G	1
Kyo, T; Mikami, Y; Murayama, SY; Myoken, Y; Sugata, T	1
Björkholm, M; Cherif, H; Kalin, M	1
Klastersky, J; Paesmans, M	1
Bennett, CL; Blum, W; Chamilos, G; Evens, A; Kennedy, L; Kontoyiannis, DP; McKoy, JM; Mehta, J; Mullane, K; Palella, F; Parada, J; Scheetz, MH; Tallman, MS; Trifilio, SM; Yarnold, PR	1
Evens, A; Frankfurt, O; Golf, M; Gordon, L; Kaniecki, K; Mehta, J; Pennick, G; Pi, J; Singhal, S; Tallman, M; Trifilio, S; Williams, S; Winter, J; Zook, J	1
Afif, C; Boktour, M; Hachem, RY; Hanna, HA; Jiang, Y; Kontoyiannis, DP; Raad, II; Torres, HA	1
Cimino, G; Gentile, G; Girmenia, C; Martino, P; Pizzarelli, G; Pozzi, E	1
Arenz, D; Böhme, A; Cornely, OA; Kiehl, MG; Kochanek, M; Pankraz, K; Reichert, D; Ullmann, AJ; Vehreschild, JJ	1
Alanio, A; Baruchel, A; Brethon, B; de Kerviler, E; Feuilhade de Chauvin, M; Lacroix, C; Leblanc, T; Menotti, J	1
Audouin, AF; Breton, P; Germaud, P; Harousseau, JL; Milpied, N; Morin, O	1
Cassone, A; Girmenia, C; Martino, P; Monaco, M; Mondello, F; Santilli, S; Tuccinardi, C	1
Blumer, JL; Lazarus, HM; Romero, A; Schlamm, H; Yanovich, S	1
Driscoll, T; Dupont, B; Ghahramani, P; Groll, AH; Hodges, M; Lutsar, I; Perfect, JR; Roden, M; Walsh, TJ	1

Reviews

17 review(s) available for voriconazole and Hematologic Malignancies

Article	Year
How different is invasive fusariosis in pediatric patients than in adults? A systematic review. Current opinion in infectious diseases, 2021, 12-01, Volume: 34, Issue:6 Topics: Adult; Antifungal Agents; Child; Fusariosis; Hematologic Neoplasms; Humans; Triazoles; Voriconazole	2021
Invasive Trichoderma spp. infections: clinical presentation and outcome of cases from the literature and the FungiScope® registry. The Journal of antimicrobial chemotherapy, 2022, 09-30, Volume: 77, Issue:10 Topics: Amphotericin B; Antifungal Agents; Caspofungin; Hematologic Neoplasms; Humans; Registries; Trichoderma; Voriconazole	2022
Central nervous system mucormycosis in a patient with hematological malignancy: A case report and review of the literature. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2022, Volume: 28, Issue:12 Topics: Adult; Amphotericin B; Antifungal Agents; Brain Abscess; Central Nervous System; Female; Hematologic Neoplasms; Humans; Mucormycosis; Voriconazole	2022
Recommendations on the use of azole antifungals in hematology-oncology patients. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2023, Volume: 36, Issue:3 Topics: Antifungal Agents; Antineoplastic Agents; Azoles; Hematologic Neoplasms; Humans; Voriconazole	2023
Central nervous system fungal infections in allogeneic stem cell transplantation. Outcome of 24 recent cases and literature review. European journal of haematology, 2020, Volume: 104, Issue:2 Topics: Adolescent; Adult; Allografts; Amphotericin B; Central Nervous System Fungal Infections; Child; Disease-Free Survival; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Survival Rate; Voriconazole	2020
Fatal Disseminated Infection by Trichosporon asahii Under Voriconazole Therapy in a Patient with Acute Myeloid Leukemia: A Review of Breakthrough Infections by Trichosporon spp. Mycopathologia, 2020, Volume: 185, Issue:2 Topics: Adult; Amphotericin B; Antifungal Agents; Central Venous Catheters; Echinocandins; Fungemia; Hematologic Neoplasms; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Male; Middle Aged; Mortality; Neutropenia; Triazoles; Trichosporon; Trichosporonosis; Voriconazole	2020
Fatal Fusarium infection manifesting as osteomyelitis following previous treatment with amphotericin B in a multi-visceral transplant: Case report and review of Fusarium infections in solid organ transplantation. Transplant infectious disease : an official journal of the Transplantation Society, 2018, Volume: 20, Issue:3 Topics: Abdomen; Amphotericin B; Antifungal Agents; Bone Marrow Transplantation; Fatal Outcome; Fusariosis; Fusarium; Hematologic Neoplasms; Humans; Immunocompromised Host; Male; Middle Aged; Osteomyelitis; Tomography, X-Ray Computed; Transplants; Voriconazole	2018
Saprochaete clavata infections in patients undergoing treatment for haematological malignancies: A report of a monocentric outbreak and review of the literature. Mycoses, 2019, Volume: 62, Issue:12 Topics: Adult; Aged; Antifungal Agents; Disease Outbreaks; Female; Fungemia; Hematologic Neoplasms; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Opportunistic Infections; Saccharomycetales; Voriconazole	2019
Treatment of fungal disease in the setting of neutropenia. Hematology. American Society of Hematology. Education Program, 2013, Volume: 2013 Topics: Anemia, Aplastic; Antifungal Agents; Candida glabrata; Candidiasis; Drug Resistance, Fungal; Fusariosis; Fusarium; Hematologic Neoplasms; Humans; Myelodysplastic Syndromes; Neutropenia; Pyrimidines; Scedosporium; Triazoles; Voriconazole	2013
Consensus guidelines for optimising antifungal drug delivery and monitoring to avoid toxicity and improve outcomes in patients with haematological malignancy, 2014. Internal medicine journal, 2014, Volume: 44, Issue:12b Topics: Antifungal Agents; Consensus; Drug Administration Schedule; Drug Delivery Systems; Drug Dosage Calculations; Drug Interactions; Drug Monitoring; Hematologic Neoplasms; Humans; Molecular Sequence Data; Mycoses; Opportunistic Infections; Practice Guidelines as Topic; Rehydration Solutions; Triazoles; Voriconazole	2014
Invasive Aspergillosis in Hematological Patients. Medical mycology journal, 2016, Volume: 57, Issue:2 Topics: Amphotericin B; Antifungal Agents; Antineoplastic Agents; Aspergillosis; Biomarkers; Echinocandins; Hematologic Neoplasms; Humans; Neutropenia; Opportunistic Infections; Risk Factors; Stem Cell Transplantation; Tomography, X-Ray Computed; Voriconazole	2016
The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Prevention of mould infections. The Journal of antimicrobial chemotherapy, 2009, Volume: 63 Suppl 1 Topics: Antifungal Agents; Chemoprevention; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Mycoses; Neutropenia; Patient Isolation; Pyrimidines; Triazoles; Voriconazole	2009
The emerging life-threatening opportunistic fungal pathogen Kodamaea ohmeri: optimal treatment and literature review. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2010, Volume: 43, Issue:3 Topics: Aged; Antifungal Agents; Diabetes Mellitus, Type 2; Echinocandins; Female; Fungemia; Hematologic Neoplasms; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Opportunistic Infections; Pyrimidines; Risk Factors; Saccharomycetales; Treatment Outcome; Triazoles; Voriconazole	2010
Antifungal prophylaxis in haematology patients: the role of voriconazole. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2012, Volume: 18 Suppl 2 Topics: Antifungal Agents; Aspergillosis; Aspergillus; Clinical Trials as Topic; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Pyrimidines; Triazoles; Voriconazole	2012
Voriconazole serum concentrations in obese and overweight immunocompromised patients: a retrospective review. Pharmacotherapy, 2013, Volume: 33, Issue:1 Topics: Body Mass Index; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Male; Middle Aged; Obesity; Overweight; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole	2013
[Update on therapy of invasive mycoses in hematology and oncology]. Deutsche medizinische Wochenschrift (1946), 2005, Jun-03, Volume: 130, Issue:22 Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Deoxycholic Acid; Drug Combinations; Echinocandins; Hematologic Neoplasms; Humans; Itraconazole; Lipopeptides; Liposomes; Mycoses; Organ Transplantation; Peptides, Cyclic; Pyrimidines; Risk Factors; Stem Cell Transplantation; Triazoles; Voriconazole; Zygomycosis	2005
Antifungal therapy in febrile neutropenic patients: review of treatment choices and strategies for aspergillar infection. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2007, Volume: 15, Issue:2 Topics: Antifungal Agents; Antineoplastic Agents; Aspergillosis; Fever; Hematologic Neoplasms; Humans; Neutropenia; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole	2007

Trials

14 trial(s) available for voriconazole and Hematologic Malignancies

Article	Year
Multicenter-Based Population Pharmacokinetic Analysis of Ciclosporin in Hematopoietic Stem Cell Transplantation Patients. Pharmaceutical research, 2019, Dec-23, Volume: 37, Issue:1 Topics: Adolescent; Adult; Aged; Body Weight; Child; Child, Preschool; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fluconazole; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Immunosuppressive Agents; Itraconazole; Male; Middle Aged; Models, Biological; Reproducibility of Results; Transplantation Conditioning; Voriconazole	2019
A drug-drug interaction study of ibrutinib with moderate/strong CYP3A inhibitors in patients with B-cell malignancies. Leukemia & lymphoma, 2018, Volume: 59, Issue:12 Topics: Adenine; Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Diarrhea; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Erythromycin; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Neutropenia; Piperidines; Polymorphism, Single Nucleotide; Pyrazoles; Pyrimidines; Voriconazole	2018
Utility of CT assessment in hematology patients with invasive aspergillosis: a post-hoc analysis of phase 3 data. BMC infectious diseases, 2019, May-28, Volume: 19, Issue:1 Topics: Adult; Anidulafungin; Female; Galactose; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Invasive Pulmonary Aspergillosis; Karnofsky Performance Status; Lung; Male; Mannans; Middle Aged; Platelet Count; Prospective Studies; Tomography, X-Ray Computed; Voriconazole	2019
Efficacy and safety of combination antifungal therapy in Korean haematological patients with invasive aspergillosis. Mycoses, 2019, Volume: 62, Issue:10 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anidulafungin; Antifungal Agents; Asian People; Double-Blind Method; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Hematologic Neoplasms; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Placebos; Survival Analysis; Treatment Outcome; Voriconazole; Young Adult	2019
Empirical voriconazole therapy for febrile neutropenic patients with hematological disorders: a prospective multicenter trial in Japan. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2013, Volume: 19, Issue:6 Topics: Adolescent; Adult; Aged; Antibiotic Prophylaxis; Antifungal Agents; Antigens, Fungal; Febrile Neutropenia; Female; Galactose; Hematologic Neoplasms; Humans; Male; Mannans; Middle Aged; Mycoses; Prospective Studies; Pyrimidines; Triazoles; Voriconazole; Young Adult	2013
Voriconazole or amphotericin B as primary therapy yields distinct early serum galactomannan trends related to outcomes in invasive aspergillosis. PloS one, 2014, Volume: 9, Issue:2 Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Biomarkers; Female; Fungal Polysaccharides; Galactose; Hematologic Neoplasms; Humans; Male; Mannans; Pyrimidines; Survival Analysis; Treatment Outcome; Triazoles; Voriconazole	2014
Combination antifungal therapy for invasive aspergillosis: a randomized trial. Annals of internal medicine, 2015, Jan-20, Volume: 162, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anidulafungin; Antifungal Agents; Aspergillosis; Double-Blind Method; Drug Therapy, Combination; Echinocandins; Female; Galactose; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Karnofsky Performance Status; Male; Mannans; Middle Aged; Platelet Count; Treatment Outcome; Voriconazole; Young Adult	2015
Comparison of micafungin and voriconazole as empirical antifungal therapies in febrile neutropenic patients with hematological disorders: a randomized controlled trial. European journal of haematology, 2016, Volume: 96, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Echinocandins; Febrile Neutropenia; Female; Hematologic Diseases; Hematologic Neoplasms; Humans; Lipopeptides; Male; Micafungin; Middle Aged; Mycoses; Treatment Outcome; Voriconazole; Young Adult	2016
Preemptive Antifungal Therapy for Febrile Neutropenic Hematological Malignancy Patients in China. Medical science monitor : international medical journal of experimental and clinical research, 2016, Nov-07, Volume: 22 Topics: Adolescent; Adult; Aged; Antifungal Agents; China; Febrile Neutropenia; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Mycoses; Survival Rate; Voriconazole; Young Adult	2016
Voriconazole-related severe adverse events: clinical application of therapeutic drug monitoring in Korean patients. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2011, Volume: 15, Issue:11 Topics: Adult; Alleles; Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Aspergillosis; Aspergillus; Cytochrome P-450 CYP2C19; Drug Monitoring; Female; Genotype; Hematologic Neoplasms; Humans; Immunocompromised Host; Infusions, Intravenous; Male; Middle Aged; Prospective Studies; Pyrimidines; Republic of Korea; Risk Factors; Triazoles; Voriconazole; Young Adult	2011
Phase II study on voriconazole for treatment of Chinese patients with malignant hematological disorders and invasive aspergillosis. Asian Pacific journal of cancer prevention : APJCP, 2012, Volume: 13, Issue:5 Topics: Administration, Oral; Antifungal Agents; Aspergillosis; Female; Follow-Up Studies; Hematologic Neoplasms; Humans; Male; Middle Aged; Prognosis; Pyrimidines; Triazoles; Voriconazole	2012
Novel antifungal agents as salvage therapy for invasive aspergillosis in patients with hematologic malignancies: posaconazole compared with high-dose lipid formulations of amphotericin B alone or in combination with caspofungin. Leukemia, 2008, Volume: 22, Issue:3 Topics: Adult; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Caspofungin; Combined Modality Therapy; Drug Combinations; Drug Therapy, Combination; Echinocandins; Female; Fungemia; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Lipopeptides; Male; Middle Aged; Neutropenia; Phosphatidylcholines; Phosphatidylglycerols; Pyrimidines; Salvage Therapy; Treatment Outcome; Triazoles; Voriconazole	2008
Safety and pharmacokinetics of oral voriconazole in patients at risk of fungal infection: a dose escalation study. Journal of clinical pharmacology, 2002, Volume: 42, Issue:4 Topics: Administration, Oral; Adult; Antifungal Agents; Dose-Response Relationship, Drug; Double-Blind Method; Female; Graft Rejection; Hematologic Neoplasms; Humans; Male; Middle Aged; Mycoses; Neoplasms; Pyrimidines; Risk Factors; Triazoles; Voriconazole	2002
Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children. The Pediatric infectious disease journal, 2002, Volume: 21, Issue:3 Topics: Adolescent; Antifungal Agents; Aspergillosis; Child; Child, Preschool; Drug Administration Schedule; Female; Granulomatous Disease, Chronic; Hematologic Neoplasms; Humans; Infant; Male; Mycoses; Pyrimidines; Treatment Failure; Triazoles; Voriconazole	2002

Other Studies

80 other study(ies) available for voriconazole and Hematologic Malignancies

Article	Year
Caspofungin-resistant Candida tropicalis strains causing breakthrough fungemia in patients at high risk for hematologic malignancies. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:11 Topics: Aged; Aged, 80 and over; Antifungal Agents; Candida tropicalis; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fungemia; Hematologic Neoplasms; Humans; Lipopeptides; Male; Middle Aged	2008
Serial plasma voriconazole concentrations after allogeneic hematopoietic stem cell transplantation. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:5 Topics: Adult; Antifungal Agents; Chemoprevention; Dose-Response Relationship, Drug; Drug Monitoring; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Mycoses; Pyrimidines; Transplantation, Homologous; Triazoles; Voriconazole	2009
UPLC-MS/MS method for the determination of voriconazole plasma concentration from pediatric patients with hematologic tumors: An application toward personalized therapy. Biomedical chromatography : BMC, 2022, Volume: 36, Issue:6 Topics: Acetonitriles; Antifungal Agents; Child; Chromatography, High Pressure Liquid; Chromatography, Liquid; Hematologic Neoplasms; Humans; Reproducibility of Results; Tandem Mass Spectrometry; Voriconazole	2022
Evaluation of voriconazole related adverse events in pediatric patients with hematological malignancies. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2023, Volume: 29, Issue:4 Topics: Antifungal Agents; Child; Hematologic Neoplasms; Humans; Prospective Studies; Retrospective Studies; Voriconazole	2023
External evaluation of population pharmacokinetic models for voriconazole in Chinese adult patients with hematological malignancy. European journal of clinical pharmacology, 2022, Volume: 78, Issue:9 Topics: Adult; Antifungal Agents; Bayes Theorem; China; Hematologic Neoplasms; Humans; Models, Biological; Triazoles; Voriconazole	2022
Impact of Inflammation on Intra-individual Variation in Trough Voriconazole Concentration in Patients with Hematological Malignancies. Biological & pharmaceutical bulletin, 2022, Volume: 45, Issue:8 Topics: Antifungal Agents; C-Reactive Protein; Drug Monitoring; Hematologic Neoplasms; Humans; Inflammation; Retrospective Studies; Voriconazole	2022
Dosage optimization of voriconazole in children with haematological malignancies based on population pharmacokinetics. Journal of clinical pharmacy and therapeutics, 2022, Volume: 47, Issue:12 Topics: Antifungal Agents; Child; Cytochrome P-450 CYP2C19; Hematologic Neoplasms; Humans; Retrospective Studies; Voriconazole	2022
Fusariosis in Mexico: A 10-year retrospective series. Medical mycology, 2023, Dec-01, Volume: 61, Issue:12 Topics: Amphotericin B; Antifungal Agents; Burns; Febrile Neutropenia; Fusariosis; Fusarium; Hematologic Neoplasms; Humans; Mexico; Retrospective Studies; Voriconazole	2023
Epidemiological aspects and characterization of the resistance profile of Journal of medical microbiology, 2019, Volume: 68, Issue:10 Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Brazil; Child; Child, Preschool; Female; Fusariosis; Fusarium; Hematologic Neoplasms; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Phylogeny; Voriconazole; Young Adult	2019
Invasive pulmonary aspergillosis in critically ill patients with hematological malignancies. Intensive care medicine, 2019, Volume: 45, Issue:12 Topics: Adult; Antifungal Agents; Female; Hematologic Neoplasms; Humans; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Mortality; Retrospective Studies; Survival Rate; Voriconazole	2019
Variability of voriconazole concentrations in patients with hematopoietic stem cell transplantation and hematological malignancies: influence of loading dose, procalcitonin, and pregnane X receptor polymorphisms. European journal of clinical pharmacology, 2020, Volume: 76, Issue:4 Topics: Antifungal Agents; Drug Monitoring; Female; Genotype; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Mycoses; Pharmacogenetics; Polymorphism, Single Nucleotide; Pregnane X Receptor; Procalcitonin; Retrospective Studies; Voriconazole	2020
Impact of CYP2C19 genotype on voriconazole exposure and effect of voriconazole on the activity of CYP3A in patients with haematological malignancies. Xenobiotica; the fate of foreign compounds in biological systems, 2021, Volume: 51, Issue:10 Topics: Antifungal Agents; Chromatography, Liquid; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Genotype; Hematologic Neoplasms; Humans; Tandem Mass Spectrometry; Voriconazole	2021
Changes in In Vitro Susceptibility Patterns of Aspergillus to Triazoles and Correlation With Aspergillosis Outcome in a Tertiary Care Cancer Center, 1999-2015. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2017, Jul-15, Volume: 65, Issue:2 Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus fumigatus; Cohort Studies; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Ergosterol; Female; Fungal Proteins; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Invasive Pulmonary Aspergillosis; Male; Microbial Sensitivity Tests; Polymorphism, Genetic; Prospective Studies; Tertiary Healthcare; Treatment Outcome; Triazoles; Voriconazole; Young Adult	2017
Assessment of high-priced systemic antifungal prescriptions. Medecine et maladies infectieuses, 2017, Volume: 47, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Lipopeptides; Male; Middle Aged; Multiple Organ Failure; Mycoses; Organ Transplantation; Retrospective Studies; Survival Rate; Treatment Outcome; Voriconazole; Young Adult	2017
Voriconazole-induced QT prolongation among hemato-oncologic patients: clinical characteristics and risk factors. European journal of clinical pharmacology, 2017, Volume: 73, Issue:9 Topics: Adult; Antifungal Agents; Electrocardiography; Female; Hematologic Neoplasms; Humans; Hypokalemia; Long QT Syndrome; Male; Middle Aged; Risk Factors; Voriconazole	2017
Comparing the safety and efficacy of voriconazole versus posaconazole in the prevention of invasive fungal infections in high-risk patients with hematological malignancies. International journal of antimicrobial agents, 2017, Volume: 50, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Chemoprevention; Drug-Related Side Effects and Adverse Reactions; Female; Hematologic Neoplasms; Hospitals, University; Humans; Invasive Fungal Infections; Male; Middle Aged; Retrospective Studies; Survival Analysis; Texas; Treatment Outcome; Triazoles; Voriconazole; Young Adult	2017
Outbreak of invasive aspergillosis in heart transplant recipients: The role of screening computed tomography scans in asymptomatic patients and universal antifungal prophylaxis. Transplant infectious disease : an official journal of the Transplantation Society, 2018, Volume: 20, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antibiotic Prophylaxis; Antifungal Agents; Asymptomatic Diseases; Cohort Studies; Disease Outbreaks; Echinocandins; Female; Galactose; Heart Transplantation; Hematologic Neoplasms; Humans; Invasive Pulmonary Aspergillosis; Lipopeptides; Male; Mannans; Mass Screening; Micafungin; Middle Aged; Retrospective Studies; Risk Factors; Tomography, X-Ray Computed; Transplant Recipients; Voriconazole	2018
An investigation of visual hallucinations associated with voriconazole administration to patients with hematological malignancies. Die Pharmazie, 2016, Nov-02, Volume: 71, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Female; Hallucinations; Hematologic Neoplasms; Humans; Incidence; Male; Middle Aged; Mycoses; Retrospective Studies; Vision Disorders; Voriconazole	2016
Sequential systematic anti-mold prophylaxis with micafungin and voriconazole results in very low incidence of invasive mold infections in patients undergoing allogeneic hematopoietic stem cell transplantation. Transplant infectious disease : an official journal of the Transplantation Society, 2018, Volume: 20, Issue:4 Topics: Adult; Aged; Antibiotic Prophylaxis; Antifungal Agents; Echinocandins; Female; Fungi; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Invasive Fungal Infections; Lipopeptides; Male; Micafungin; Middle Aged; Retrospective Studies; Transplantation, Homologous; Treatment Outcome; Voriconazole; Young Adult	2018
Posaconazole vs. voriconazole in the prevention of invasive fungal diseases in patients with haematological malignancies: A retrospective study. Journal de mycologie medicale, 2018, Volume: 28, Issue:2 Topics: Adolescent; Adult; Aged; Antifungal Agents; Child; China; Cost-Benefit Analysis; Female; Fluconazole; Hematologic Neoplasms; Humans; Invasive Fungal Infections; Itraconazole; Male; Middle Aged; Retrospective Studies; Triazoles; Voriconazole; Young Adult	2018
Evaluating a voriconazole dose modification guideline to optimize dosing in patients with hematologic malignancies. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2019, Volume: 25, Issue:6 Topics: Adult; Age Factors; Aged; Antifungal Agents; Body Mass Index; Female; Hematologic Neoplasms; Humans; Invasive Fungal Infections; Male; Middle Aged; Practice Guidelines as Topic; Prospective Studies; Voriconazole; Young Adult	2019
Voriconazole Resistance and Mortality in Invasive Aspergillosis: A Multicenter Retrospective Cohort Study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2019, 04-24, Volume: 68, Issue:9 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillus fumigatus; Autoimmune Diseases; Child; Child, Preschool; Drug Resistance, Fungal; Female; Hematologic Neoplasms; Humans; Invasive Pulmonary Aspergillosis; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Survival Analysis; Time Factors; Voriconazole	2019
Treating invasive aspergillosis in patients with hematologic malignancy: diagnostic-driven approach versus empiric therapies. BMC infectious diseases, 2018, Dec-13, Volume: 18, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Empiricism; Female; Hematologic Neoplasms; Humans; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Precision Medicine; Prognosis; Retrospective Studies; Standard of Care; Survival Analysis; Treatment Outcome; Voriconazole; Young Adult	2018
Impact of dose adaptations following voriconazole therapeutic drug monitoring in pediatric patients. Medical mycology, 2019, Nov-01, Volume: 57, Issue:8 Topics: Adolescent; Antifungal Agents; Child; Child, Preschool; Drug Monitoring; Female; Hematologic Neoplasms; Humans; Immunocompromised Host; Infant; Infant, Newborn; Invasive Pulmonary Aspergillosis; Male; Retrospective Studies; Serum; Voriconazole	2019
Combination antifungal treatment for invasive fungal disease after hematopoietic stem cell transplantation in children with hematological disorders. Transplant infectious disease : an official journal of the Transplantation Society, 2019, Volume: 21, Issue:3 Topics: Adolescent; Amphotericin B; Antifungal Agents; Caspofungin; Child; Child, Preschool; Drug Therapy, Combination; Female; Hematologic Diseases; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Infant; Invasive Fungal Infections; Male; Mycoses; Retrospective Studies; Survival Analysis; Transplantation, Homologous; Treatment Outcome; Voriconazole	2019
Model-based Voriconazole Dose Optimization in Chinese Adult Patients With Hematologic Malignancies. Clinical therapeutics, 2019, Volume: 41, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Area Under Curve; China; Hematologic Neoplasms; Humans; Invasive Fungal Infections; Middle Aged; Models, Statistical; Prospective Studies; Voriconazole; Young Adult	2019
Prevalence of voriconazole-resistant invasive aspergillosis and its impact on mortality in haematology patients. The Journal of antimicrobial chemotherapy, 2019, 09-01, Volume: 74, Issue:9 Topics: Aged; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Drug Therapy, Combination; Female; Fungal Proteins; Hematologic Neoplasms; Humans; Invasive Fungal Infections; Male; Microbial Sensitivity Tests; Middle Aged; Mortality; Mutation; Prevalence; Prognosis; Retrospective Studies; Survival Analysis; Voriconazole	2019
Voriconazole therapeutic drug monitoring: retrospective cohort study of the relationship to clinical outcomes and adverse events. BMC infectious diseases, 2013, Feb-26, Volume: 13 Topics: Adult; Antifungal Agents; Brain Diseases, Metabolic; Candidiasis; Drug Administration Schedule; Drug Monitoring; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Liver; Male; Middle Aged; Pulmonary Aspergillosis; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole	2013
Severe skin toxicity in pediatric oncology patients treated with voriconazole and concomitant methotrexate. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:6 Topics: Adolescent; Antibiotic Prophylaxis; Antifungal Agents; Antimetabolites, Antineoplastic; Aspergillosis; Cheilitis; Child; Child, Preschool; Dermatitis, Photoallergic; Drug Therapy, Combination; Female; Hematologic Neoplasms; Humans; Infant; Infant, Newborn; Leukemia, Megakaryoblastic, Acute; Male; Methotrexate; Pyrimidines; Skin; Treatment Outcome; Triazoles; Voriconazole	2013
Potential factors for inadequate voriconazole plasma concentrations in intensive care unit patients and patients with hematological malignancies. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:7 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Body Mass Index; Cohort Studies; Drug Monitoring; Female; Hematologic Neoplasms; Humans; Intensive Care Units; Male; Middle Aged; Prospective Studies; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult	2013
Dosing algorithm for concomitant administration of sirolimus, tacrolimus, and an azole after allogeneic hematopoietic stem cell transplantation. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2015, Volume: 21, Issue:6 Topics: Adult; Aged; Algorithms; Antifungal Agents; Azoles; Drug Dosage Calculations; Female; Fluconazole; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycoses; Retrospective Studies; Sirolimus; Tacrolimus; Triazoles; Voriconazole; Young Adult	2015
Elevated fluoride levels and periostitis in pediatric hematopoietic stem cell transplant recipients receiving long-term voriconazole. Pediatric blood & cancer, 2015, Volume: 62, Issue:5 Topics: Adult; Antifungal Agents; Bone Diseases; Child; Child, Preschool; Combined Modality Therapy; Female; Fluorides; Follow-Up Studies; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Infant; Male; Periostitis; Prognosis; Transplant Recipients; Voriconazole; Young Adult	2015
Clinical experience of the use of voriconazole, caspofungin or the combination in primary and salvage therapy of invasive aspergillosis in haematological malignancies. International journal of antimicrobial agents, 2015, Volume: 45, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Caspofungin; Child; Drug Therapy, Combination; Echinocandins; Female; Hematologic Neoplasms; Humans; Invasive Pulmonary Aspergillosis; Lipopeptides; Male; Middle Aged; Retrospective Studies; Salvage Therapy; Survival Analysis; Treatment Outcome; Voriconazole; Young Adult	2015
Acremonium species associated fungemia: a novel pathogen in the immunosuppressed patient. Boletin de la Asociacion Medica de Puerto Rico, 2014, Volume: 106, Issue:3 Topics: Acremonium; Aged; Amphotericin B; Antifungal Agents; Diagnosis, Differential; Female; Fungemia; Hematologic Neoplasms; Humans; Immunocompromised Host; Male; Treatment Outcome; Voriconazole	2014
Putting CYP2C19 genotyping to the test: utility of pharmacogenomic evaluation in a voriconazole-treated haematology cohort. The Journal of antimicrobial chemotherapy, 2015, Volume: 70, Issue:4 Topics: Aged; Antifungal Agents; Cohort Studies; Cytochrome P-450 CYP2C19; Female; Genotyping Techniques; Hematologic Neoplasms; Humans; Male; Middle Aged; Mycoses; Pharmacogenetics; Pilot Projects; Treatment Outcome; Voriconazole	2015
Safety of voriconazole and sirolimus coadministration after allogeneic hematopoietic SCT. Bone marrow transplantation, 2015, Volume: 50, Issue:3 Topics: Adult; Aged; Antibiotics, Antineoplastic; Antifungal Agents; Drug Interactions; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Sirolimus; Transplantation, Homologous; Voriconazole; Young Adult	2015
Celebrating the ACP centennial: from the annals archive. Annals of internal medicine, 2015, Jan-20, Volume: 162, Issue:2 Topics: Anidulafungin; Antifungal Agents; Aspergillosis; Echinocandins; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Voriconazole	2015
Variability of voriconazole plasma concentrations after allogeneic hematopoietic stem cell transplantation: impact of cytochrome p450 polymorphisms and comedications on initial and subsequent trough levels. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:4 Topics: Adult; Antifungal Agents; Aspergillosis; Cytochrome P-450 Enzyme System; Diarrhea; Drug Interactions; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Individuality; Male; Middle Aged; Polymorphism, Genetic; Proton Pump Inhibitors; Voriconazole	2015
Voriconazole exposure and the risk of cutaneous squamous cell carcinoma in allogeneic hematopoietic stem cell transplant patients. Transplant infectious disease : an official journal of the Transplantation Society, 2015, Volume: 17, Issue:2 Topics: Adult; Aged; Antifungal Agents; Carcinoma, Squamous Cell; Cohort Studies; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Middle Aged; Mycoses; Retrospective Studies; Risk Factors; Skin Neoplasms; Transplantation, Homologous; Voriconazole; Young Adult	2015
Epidemiological and mycological characteristics of candidemia in patients with hematological malignancies attending a tertiary-care center in India. Hematology/oncology and stem cell therapy, 2015, Volume: 8, Issue:3 Topics: Amphotericin B; Candida albicans; Candida tropicalis; Candidemia; Cross-Sectional Studies; Female; Hematologic Neoplasms; Humans; India; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Nystatin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prevalence; Risk Factors; Tertiary Care Centers; Voriconazole	2015
Invasive infection due to Saprochaete capitata in a young patient with hematological malignancies. Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology], 2015, Volume: 46, Issue:2 Topics: Adolescent; Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fungemia; Hematologic Neoplasms; Humans; Lipopeptides; Lung; Male; Microbial Sensitivity Tests; Microbiological Techniques; Microscopy; Radiography, Thoracic; Saccharomycetales; Treatment Outcome; Voriconazole	2015
The Clinical Significance of Voriconazole Therapeutic Drug Monitoring in Children With Invasive Fungal Infections. Pediatric hematology and oncology, 2015, Volume: 32, Issue:8 Topics: Adolescent; Child; Child, Preschool; Female; Hematologic Neoplasms; Humans; Male; Mycoses; Organ Transplantation; Time Factors; Voriconazole	2015
Variability of Voriconazole Trough Levels in Haematological Patients: Influence of Comedications with cytochrome P450(CYP) Inhibitors and/or with CYP Inhibitors plus CYP Inducers. Basic & clinical pharmacology & toxicology, 2016, Volume: 118, Issue:6 Topics: Adult; Antifungal Agents; Antineoplastic Agents; Cytochrome P-450 Enzyme Inducers; Cytochrome P-450 Enzyme Inhibitors; Drug Interactions; Drug Monitoring; Female; Hematologic Neoplasms; Humans; Invasive Fungal Infections; Italy; Male; Middle Aged; Practice Guidelines as Topic; Retrospective Studies; Treatment Outcome; Voriconazole	2016
Therapeutic drug monitoring and safety of intravenous voriconazole formulated with sulfobutylether β-cyclodextrin in haematological patients with renal impairment. Mycoses, 2016, Volume: 59, Issue:10 Topics: Administration, Intravenous; Adolescent; Adult; Antifungal Agents; Aspergillosis; beta-Cyclodextrins; Creatinine; Cytochrome P-450 CYP2C19; Drug Compounding; Drug Monitoring; Female; Hematologic Neoplasms; Humans; Invasive Fungal Infections; Male; Middle Aged; Prospective Studies; Renal Insufficiency; Voriconazole; Young Adult	2016
Different effects of lansoprazole and rabeprazole on the plasma voriconazole trough levels in allogeneic hematopoietic cell transplant recipients. Annals of hematology, 2016, Volume: 95, Issue:11 Topics: Administration, Oral; Adolescent; Adult; Aged; Antifungal Agents; Body Weight; Bone Marrow Transplantation; Cord Blood Stem Cell Transplantation; Drug Interactions; Drug Monitoring; Female; Hematologic Neoplasms; Humans; Injections, Intravenous; Lansoprazole; Male; Middle Aged; Mycoses; Myelodysplastic Syndromes; Postoperative Complications; Rabeprazole; Retrospective Studies; Transplantation Conditioning; Transplantation, Homologous; Voriconazole; Young Adult	2016
How common is subsequent central nervous system toxicity in asymptomatic patients with haematologic malignancy and supratherapeutic voriconazole serum levels? Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2017, Volume: 23, Issue:6 Topics: Adult; Age Factors; Aged; Antifungal Agents; Central Nervous System; Cognitive Dysfunction; Consciousness Disorders; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Retrospective Studies; Vision Disorders; Voriconazole	2017
Pharmacokinetic-pharmacodynamic analysis of voriconazole in Japanese patients with hematological malignancies. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2008, Volume: 27, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Asian People; Female; Hematologic Neoplasms; Humans; Male; Metabolic Clearance Rate; Middle Aged; Monte Carlo Method; Mycoses; Pyrimidines; Tissue Distribution; Triazoles; Voriconazole	2008
Visual disturbance comorbid with hallucination caused by voriconazole in the Japanese population. International journal of hematology, 2008, Volume: 88, Issue:1 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antifungal Agents; Asian People; Female; Hallucinations; Hematologic Neoplasms; Humans; Japan; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole	2008
Pulmonary aspergillosis in hematologic malignancies: lights and shadows. Haematologica, 2008, Volume: 93, Issue:11 Topics: Antifungal Agents; Aspergillosis; Hematologic Neoplasms; Humans; Lung Diseases; Pyrimidines; Sensitivity and Specificity; Triazoles; Voriconazole	2008
Susceptibility to voriconazole, fluconazole, and ketoconazole of yeast isolated from patients with hematological malignancies. Journal of chemotherapy (Florence, Italy), 2008, Volume: 20, Issue:6 Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Hematologic Neoplasms; Humans; Ketoconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole	2008
Monitoring trough concentration of voriconazole is important to ensure successful antifungal therapy and to avoid hepatic damage in patients with hematological disorders. International journal of hematology, 2009, Volume: 89, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Dose-Response Relationship, Drug; Drug Monitoring; Hematologic Neoplasms; Humans; Liver Diseases; Male; Middle Aged; Mycoses; Pyrimidines; Triazoles; Voriconazole; Young Adult	2009
A rescue therapy with a combination of caspofungin and liposomal amphotericin B or voriconazole in children with haematological malignancy and refractory invasive fungal infections. Mycoses, 2011, Volume: 54, Issue:3 Topics: Adolescent; Amphotericin B; Antifungal Agents; Caspofungin; Child; Child, Preschool; Drug Resistance, Fungal; Drug Therapy, Combination; Echinocandins; Female; Fungi; Hematologic Neoplasms; Humans; Infant; Lipopeptides; Male; Mycoses; Pyrimidines; Salvage Therapy; Treatment Outcome; Triazoles; Voriconazole	2011
Invasive respiratory aspergillosis is a treatable disease with early diagnosis and aggressive therapy. Pediatric hematology and oncology, 2010, Volume: 27, Issue:6 Topics: Amphotericin B; Antifungal Agents; Caspofungin; Child; Early Diagnosis; Echinocandins; Female; Fever; Hematologic Neoplasms; Humans; Lipopeptides; Male; Neutropenia; Prognosis; Pulmonary Aspergillosis; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole	2010
Increasing incidence of mucormycosis in University Hospital, Belgium. Emerging infectious diseases, 2010, Volume: 16, Issue:9 Topics: Adolescent; Adult; Aged; Antifungal Agents; Belgium; Child; Female; Hematologic Neoplasms; Hospitals, University; Humans; Incidence; Male; Middle Aged; Mucormycosis; Pyrimidines; Risk Factors; Triazoles; Voriconazole; Young Adult	2010
Galactomannan testing in bronchoalveolar lavage fluid facilitates the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies and stem cell transplant recipients. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2011, Volume: 17, Issue:7 Topics: Aged; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillus fumigatus; Biomarkers; Biopsy; Bronchoalveolar Lavage Fluid; Female; Galactose; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Male; Mannans; Middle Aged; Postoperative Complications; Pyrimidines; Retrospective Studies; Sensitivity and Specificity; Triazoles; Voriconazole	2011
Low prevalence of resistance to azoles in Aspergillus fumigatus in a French cohort of patients treated for haematological malignancies. The Journal of antimicrobial chemotherapy, 2011, Volume: 66, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Cohort Studies; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Female; France; Fungal Proteins; Hematologic Neoplasms; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Pyrimidines; Triazoles; Tubulin; Voriconazole	2011
Rapid progression and unusual premortal diagnosis of mucormycosis in patients with hematologic malignancies: analysis of eight patients. International journal of hematology, 2011, Volume: 93, Issue:3 Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Biopsy; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Mucormycosis; Neutropenia; Pyrimidines; Retrospective Studies; Survival Rate; Triazoles; Voriconazole	2011
Invasive Myceliophthora thermophila infection mimicking invasive aspergillosis in a neutropenic patient: a new cause of cross-reactivity with the Aspergillus galactomannan serum antigen assay. Medical mycology, 2011, Volume: 49, Issue:8 Topics: Antifungal Agents; Antigens, Fungal; Aspergillosis; Aspergillus; Base Sequence; Cross Reactions; Diagnosis, Differential; Galactose; Hematologic Neoplasms; Humans; Male; Mannans; Middle Aged; Molecular Sequence Data; Mycoses; Neutropenia; Pyrimidines; Sensitivity and Specificity; Sordariales; Spores, Fungal; Triazoles; Voriconazole	2011
[Efficacy of voriconazole for treatment of invasive fungal infections in 87 cases with hematologic malignancies]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2011, Volume: 32, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult	2011
[Outcome analysis of caspofungin in combination with voriconazole for treatment of 12 hematologic malignancies cases with invasive fungal infection]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2011, Volume: 32, Issue:8 Topics: Adolescent; Adult; Aged; Antifungal Agents; Caspofungin; Drug Therapy, Combination; Echinocandins; Female; Hematologic Neoplasms; Humans; Lipopeptides; Male; Middle Aged; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult	2011
Persistent poor long-term prognosis of allogeneic hematopoietic stem cell transplant recipients surviving invasive aspergillosis. Haematologica, 2012, Volume: 97, Issue:9 Topics: Adolescent; Adult; Antifungal Agents; Aspergillosis; Aspergillus; Cause of Death; Child; Child, Preschool; Female; Follow-Up Studies; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Male; Middle Aged; Prognosis; Retrospective Studies; Survival Rate; Time Factors; Voriconazole; Young Adult	2012
Initial voriconazole trough blood levels and clinical outcomes of invasive aspergillosis in patients with hematologic malignancies. Medical mycology, 2013, Volume: 51, Issue:3 Topics: Adult; Aged; Antifungal Agents; Female; Hematologic Neoplasms; Humans; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Pyrimidines; Republic of Korea; Tertiary Care Centers; Treatment Outcome; Triazoles; Voriconazole; Young Adult	2013
Reversible skeletal disease and high fluoride serum levels in hematologic patients receiving voriconazole. Blood, 2012, Sep-20, Volume: 120, Issue:12 Topics: Adult; Antifungal Agents; Bone Diseases; Female; Fluorides; Hematologic Neoplasms; Humans; Itraconazole; Middle Aged; Muscle, Skeletal; Periostitis; Pyrimidines; Retrospective Studies; Stem Cell Transplantation; Transplantation, Homologous; Triazoles; Voriconazole	2012
The surgical management of rhinocerebral mucormycosis. Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery, 2013, Volume: 41, Issue:4 Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Brain Diseases; Cause of Death; Combined Modality Therapy; Diagnosis, Differential; Fatal Outcome; Female; Hematologic Neoplasms; Humans; Immunocompromised Host; Male; Maxillary Sinusitis; Middle Aged; Mucormycosis; Nose Diseases; Paranasal Sinus Diseases; Pyrimidines; Triazoles; Voriconazole; Young Adult	2013
Effect of combined fluoroquinolone and azole use on QT prolongation in hematology patients. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:3 Topics: Adult; Aged; Antifungal Agents; Drug Administration Schedule; Drug Therapy, Combination; Electrocardiography; Female; Fluconazole; Hematologic Neoplasms; Humans; Hypokalemia; Levofloxacin; Long QT Syndrome; Male; Middle Aged; Mycoses; Ofloxacin; Pyrimidines; Risk Factors; Torsades de Pointes; Triazoles; Ventricular Dysfunction, Left; Voriconazole	2013
Voriconazole for invasive aspergillosis in oncohematological patients: a single-center pediatric experience. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2003, Volume: 11, Issue:11 Topics: Adolescent; Amphotericin B; Anemia, Aplastic; Anemia, Refractory; Antifungal Agents; Antineoplastic Agents; Aspergillosis; Bone Marrow Transplantation; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Hematologic Neoplasms; Humans; Leukemia, Myelomonocytic, Acute; Male; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Time Factors; Treatment Outcome; Triazoles; Voriconazole	2003
Salvage therapy with voriconazole for invasive fungal infections in patients failing or intolerant to standard antifungal therapy. Transplantation, 2003, Dec-15, Volume: 76, Issue:11 Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Bone Marrow Transplantation; Child; Drug Resistance, Fungal; Female; Hematologic Neoplasms; Humans; Immunocompromised Host; Middle Aged; Mycoses; Neoplasms; Pyrimidines; Salvage Therapy; Transplantation; Treatment Failure; Triazoles; Voriconazole	2003
In vitro pharmacodynamic characteristics of amphotericin B, caspofungin, fluconazole, and voriconazole against bloodstream isolates of infrequent Candida species from patients with hematologic malignancies. Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:11 Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Caspofungin; Colony Count, Microbial; Echinocandins; Fluconazole; Hematologic Neoplasms; Humans; Kinetics; Lipopeptides; Microbial Sensitivity Tests; Models, Biological; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole	2004
Voriconazole therapeutic drug monitoring in allogeneic hematopoietic stem cell transplant recipients. Bone marrow transplantation, 2005, Volume: 35, Issue:5 Topics: Alkaline Phosphatase; Antifungal Agents; Aspartate Aminotransferases; Chromatography, High Pressure Liquid; Drug Monitoring; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Premedication; Pyrimidines; Retrospective Studies; Transplantation, Homologous; Triazoles; Voriconazole	2005
Epidemiology and outcome of infections due to Aspergillus terreus: 10-year single centre experience. British journal of haematology, 2005, Volume: 131, Issue:2 Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Austria; Caspofungin; Drug Resistance, Fungal; Echinocandins; Female; Genes, Fungal; Hematologic Neoplasms; Humans; Lipopeptides; Lung Diseases, Fungal; Male; Middle Aged; Opportunistic Infections; Organ Transplantation; Peptides, Cyclic; Prevalence; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole	2005
Mucormycoses in patients with hematologic malignancies: an emerging fungal infection. Haematologica, 2005, Volume: 90 Suppl Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Communicable Diseases, Emerging; Dermatomycoses; Disease Susceptibility; Female; Fluconazole; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Itraconazole; Lung Diseases, Fungal; Male; Middle Aged; Mucormycosis; Neutropenia; Pyrimidines; Sinusitis; Transplantation Conditioning; Triazoles; Viscera; Voriconazole	2005
Breakthrough fungemia caused by fluconazole-resistant Candida albicans with decreased susceptibility to voriconazole in patients with hematologic malignancies. Haematologica, 2006, Volume: 91, Issue:2 Topics: Candida albicans; Candidiasis; Drug Resistance; Fluconazole; Fungemia; Hematologic Neoplasms; Humans; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole	2006
Antifungal therapy in patients with hematological malignancies: how to avoid overtreatment? European journal of haematology, 2006, Volume: 77, Issue:4 Topics: Adult; Aged; Antifungal Agents; Caspofungin; Echinocandins; Female; Hematologic Neoplasms; Humans; Lipopeptides; Male; Middle Aged; Mycoses; Peptides, Cyclic; Prospective Studies; Pyrimidines; Triazoles; Voriconazole	2006
Breakthrough zygomycosis after voriconazole administration among patients with hematologic malignancies who receive hematopoietic stem-cell transplants or intensive chemotherapy. Bone marrow transplantation, 2007, Volume: 39, Issue:7 Topics: Adolescent; Adult; Aged; Amphotericin B; Child; Child, Preschool; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Zygomycosis	2007
Monitoring plasma voriconazole levels may be necessary to avoid subtherapeutic levels in hematopoietic stem cell transplant recipients. Cancer, 2007, Apr-15, Volume: 109, Issue:8 Topics: Antifungal Agents; Graft Rejection; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Mycoses; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole	2007
Improving outcomes of acute invasive Aspergillus rhinosinusitis in patients with hematologic malignancies or aplastic anemia: the role of voriconazole. Haematologica, 2008, Volume: 93, Issue:1 Topics: Acute Disease; Adolescent; Adult; Aged; Anemia, Aplastic; Aspergillosis; Child; Cohort Studies; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole	2008
Treatment of invasive fungal infections in clinical practice: a multi-centre survey on customary dosing, treatment indications, efficacy and safety of voriconazole. International journal of hematology, 2008, Volume: 87, Issue:2 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antifungal Agents; Female; Hematologic Neoplasms; Humans; Infusions, Intravenous; Male; Middle Aged; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole	2008
Invasive pulmonary infection due to Trichoderma longibrachiatum mimicking invasive Aspergillosis in a neutropenic patient successfully treated with voriconazole combined with caspofungin. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2008, May-15, Volume: 46, Issue:10 Topics: Adolescent; Antifungal Agents; Caspofungin; Diagnosis, Differential; Drug Therapy, Combination; Echinocandins; Hematologic Neoplasms; Humans; Lipopeptides; Male; Mycoses; Neutropenia; Pneumonia; Pyrimidines; Radiography, Thoracic; Tomography, X-Ray Computed; Triazoles; Trichoderma; Voriconazole	2008
[Rare pulmonary mycoses in patients with hematologic diseases]. Revue de pneumologie clinique, 1998, Volume: 54, Issue:5 Topics: Acremonium; Adolescent; Adult; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Bone Marrow Transplantation; Female; Hematologic Neoplasms; Humans; Imidazoles; Leukemia, Myeloid, Acute; Lung; Lung Diseases, Fungal; Male; Middle Aged; Multiple Myeloma; Neutropenia; Penicillium; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pseudallescheria; Pyrimidines; Risk Factors; Triazoles; Voriconazole	1998
In vitro activity of fluconazole and voriconazole against isolates of Candida albicans from patients with haematological malignancies. The Journal of antimicrobial chemotherapy, 2000, Volume: 46, Issue:3 Topics: Antifungal Agents; Candida albicans; Candidiasis; Fluconazole; Hematologic Neoplasms; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole	2000